FimmCyte Overview

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 10

FimmCyte General Information

Description

Developer of antibody-based immunotherapies designed to treat chronic fibro-inflammatory diseases. The company offers targeted immunotherapies that eliminate diseased fibrotic tissue while preserving healthy tissue, enabling healthcare providers to treat endometriosis and other fibro-inflammatory conditions with disease-modifying therapies.

Contact Information

Website
www.fimmcyte.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Hochbergerstrasse 60C
  • 4057 Basel
  • Switzerland
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Hochbergerstrasse 60C
  • 4057 Basel
  • Switzerland

FimmCyte Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

FimmCyte Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Accelerator/Incubator 01-Jan-2026 Completed Pre-Clinical Trials
10. Later Stage VC 23-Dec-2024 Completed Pre-Clinical Trials
9. Accelerator/Incubator 06-Oct-2023 Completed Pre-Clinical Trials
8. Accelerator/Incubator 05-Sep-2023 Completed Pre-Clinical Trials
7. Seed Round Completed Pre-Clinical Trials
6. Seed Round 08-Jun-2022 Completed Pre-Clinical Trials
5. Accelerator/Incubator 01-Jan-2022 Completed Pre-Clinical Trials
4. Grant 01-Dec-2021 Completed Pre-Clinical Trials
3. Grant 28-Sep-2021 $11.8K Completed Pre-Clinical Trials
2. Grant 01-Sep-2020 $1.03M Completed Pre-Clinical Trials
To view FimmCyte’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

FimmCyte Patents

  • 6

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 6

    Pending

  • Expiring in next 12 mo

FimmCyte Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026209911-A1 Fap targeting agents comprising immunomodulatory moieties, methods and uses thereof Pending 04-Apr-2025
WO-2026209914-A1 Fap targeting agents comprising phagocytosis modulating moieties, methods and uses thereof Pending 04-Apr-2025
WO-2026190361-A1 Fap binders with internalisation capability, methods and uses thereof Pending 14-Mar-2025
AU-2025212584-A1 Antigen binding molecules selective for cellular fibroblast activation protein (fap) over soluble fap Pending 26-Jan-2024
EP-4762097-A1 Antigen binding molecules selective for cellular fibroblast activation protein (fap) over soluble fap Pending 26-Jan-2024 C07K16/40
To view FimmCyte’s complete patent history, request access »

FimmCyte Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

FimmCyte Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Nordic Mentor Network For Entrepreneurship Accelerator/Incubator
Kickfund Venture Capital Minority
UZH Lifesciences Fund Venture Capital Minority
BaseLaunch Accelerator/Incubator Minority
University of Zürich University Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

FimmCyte FAQs

  • Where is FimmCyte headquartered?

    FimmCyte is headquartered in Basel, Switzerland.

  • What is the size of FimmCyte?

    FimmCyte has 7 total employees.

  • What industry is FimmCyte in?

    FimmCyte’s primary industry is Drug Discovery.

  • Is FimmCyte a private or public company?

    FimmCyte is a Private company.

  • What is FimmCyte’s current revenue?

    The current revenue for FimmCyte is .

  • How much funding has FimmCyte raised over time?

    FimmCyte has raised $6.71M.

  • Who are FimmCyte’s investors?

    Nordic Mentor Network For Entrepreneurship, Kickfund, UZH Lifesciences Fund, BaseLaunch, and University of Zürich are 5 of 10 investors who have invested in FimmCyte.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process